Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 5,680 | 5,399 | 3,231 | 2,505 | 4,218 |
| Gross Profit | 5,680 | 5,399 | 3,231 | 2,505 | 4,218 |
| Operating Expenses | 46,506 | 59,444 | 66,539 | 79,003 | 79,480 |
| Operating Income | -40,826 | -54,045 | -63,308 | -76,498 | -75,262 |
| Interest Expense | 3,513 | 3,512 | 3,511 | 3,512 | 2,430 |
| Other Income | 485 | 448 | 565 | 659 | 440 |
| Pre-tax Income | -43,854 | -57,109 | -66,254 | -79,351 | -77,252 |
| Net Income Continuous | -43,854 | -57,109 | -66,254 | -79,351 | -77,252 |
| Net Income | $-43,854 | $-57,109 | $-66,254 | $-79,351 | $-77,252 |
| EPS Basic Total Ops | -3.20 | -4.20 | -4.80 | -5.80 | -5.80 |
| EPS Basic Continuous Ops | -3.20 | -4.21 | -4.89 | -5.86 | -5.72 |
| EPS Diluted Total Ops | -3.20 | -4.20 | -4.80 | -5.80 | -5.80 |
| EPS Diluted Continuous Ops | -3.20 | -4.21 | -4.89 | -5.86 | -5.72 |
| EBITDA(a) | $-38,359 | $-51,471 | $-60,731 | $-74,176 | $-72,925 |